Vertex Pharmaceuticals Incorporated vs Workday Inc — how do they compare? Vertex Pharmaceuticals Incorporated trades at $481.47 (market cap $121.95B), while Workday Inc trades at $140.92 (market cap $36.36B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 3.4× Workday Inc's market cap, and Vertex Pharmaceuticals Incorporated is trading nearer its 52-week high, Workday Inc nearer its low. Which is the better fit depends on your goals.
| VRTX | WDAY | |
|---|---|---|
Market Cap | $121.95B | $36.36B |
Sector | Health | Technology |
52-Week High | $529.59 | $247.69 |
52-Week Low | $366.54 | $112.55 |
Enterprise Value | $116.69B | $35.81B |
Trailing returns across standard periods
Latest headlines on both assets
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.
Read more on WDAY →